Logo
G

GLG Pharma

5 employees

GLG Pharma Personalized Medicine for Oncology using STAT3 inhibitors and novel cancer culture called Gx-C3

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
CLL
FDA
Triple Negative Breast Cancer
Cancer cell growth inhibition with p-STAT3 blockers
GIST
Health Care
Ovarian Cancer
Breast Cancer
STAT3 diagnostic
Glioma
STAT3
Lung Cancer
Repurposed drug GLG-801

Date founded

2009

Funding rounds raised

G

GLG Pharma raised undisclosed on October 16, 2012

Investors: Institute for Commercialization of Florida Technology

G

GLG Pharma raised undisclosed on May 10, 2012

Investors: Institute for Commercialization of Florida Technology

FAQ